|
Q3 2024
Filed on Nov 14, 2024
|
45,584
|
$1.82 - $3.17
$83K - $145K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
10,456
|
$175.1 - $223.38
$1.83M - $2.34M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
24,735
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,967
|
$116.28 - $141.69
$1.39M - $1.7M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
2,100
|
$107.14 - $151.82
$225K - $319K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
26,185
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
98,597
|
$7.36 - $9.66
$726K - $952K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,098
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
123,442
|
$6.45 - $9.23
$796K - $1.14M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
15,301
|
$5.37 - $7.28
$82.2K - $111K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
33,770
|
$25.77 - $35.16
$870K - $1.19M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,500
|
$3.31 - $5.54
$44.7K - $74.8K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
42,953
|
$4.49 - $7.2
$193K - $309K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,923
|
$0.57 - $0.97
$7.94K - $13.5K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
46,230
|
$70.41 - $88.25
$3.26M - $4.08M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
104,779
|
$25.5 - $43.57
$2.67M - $4.57M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
309,004
|
$17.21 - $25.28
$5.32M - $7.81M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
44,776
|
$31.4 - $39.07
$1.41M - $1.75M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
7,286
|
$141.97 - $159.66
$1.03M - $1.16M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
90,074
|
$47.6 - $53.31
$4.29M - $4.8M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
181,986
|
$41.77 - $67.84
$7.6M - $12.3M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
27,111
|
$3.93 - $4.91
$107K - $133K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
52,958
|
$0.29 - $0.51
$15.4K - $27K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
5,739
|
$83.58 - $107.82
$480K - $619K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
23,369
|
$4.48 - $5.62
$105K - $131K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
22,524
|
$1.12 - $1.4
$25.2K - $31.5K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
3,395
|
$222.88 - $275.47
$757K - $935K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
2,825
|
$92.85 - $119.61
$262K - $338K
|
|
Adverum Biotechnologies Inc
|
Q3 2024
Filed on Nov 14, 2024
|
24,203
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
76,137
|
$82.37 - $103.25
$6.27M - $7.86M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,733
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,400
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,463
|
$0.54 - $0.92
$6.19K - $10.5K
|
|
Allarity Therapeutics Inc
|
Q3 2024
Filed on Nov 14, 2024
|
38,795
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,312
|
$0.48 - $13.79
$8.79K - $253K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
23,426
|
$20.48 - $33.15
$480K - $777K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
169,348
|
$2.08 - $3.5
$352K - $593K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
14,565
|
$0.7 - $0.82
$10.2K - $11.9K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
281,000
|
$5.5 - $8.1
$1.55M - $2.28M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
140,000
|
$1.81 - $8.13
$253K - $1.14M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
22,637
|
$78.13 - $87.85
$1.77M - $1.99M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,224
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
26,400
|
$12.3 - $20.68
$325K - $546K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
32,300
|
$18.42 - $32.42
$595K - $1.05M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
40,972
|
$0.25 - $11.23
$10.2K - $460K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
20,200
|
$48.61 - $65.14
$982K - $1.32M
|
|
Annaly Capital Management Inc
|
Q3 2024
Filed on Nov 14, 2024
|
21,835
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
69,966
|
$13.39 - $15.16
$937K - $1.06M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
53,235
|
$4.35 - $8.5
$232K - $452K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
130,920
|
$2.4 - $5.09
$314K - $666K
|
|